Mark Worthington serves as Executive at Athira Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Mark Worthington has executed 17 insider transactions totaling $31.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved selling 876 shares valued at $6.0K.
Mark Worthington currently holds 13,978 shares of Athira Pharma, Inc. (ATHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Worthington has been a net seller of ATHA stock. They have purchased $0 and sold $31.0K worth of shares.
Mark Worthington's most recent insider trade was on Jan 2, 2026, when they sold 876 shares at $6.88 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 31, 2025 | ATHA | $0 | Option Exercise | 3,667 | $N/A | Discretionary |
| Jul 1, 2025 | ATHA | $2.5K | Sale | 8,526 | $0.29 | Discretionary |
| Jun 30, 2025 | ATHA | $0 | Option Exercise | 36,666 | $N/A | Discretionary |
| Sep 5, 2024 | ATHA | $1.4K | Sale | 2,525 | $0.57 | Discretionary |
| Sep 3, 2024 | ATHA | $0 | Award | 10,000 | $N/A | Discretionary |
| May 20, 2024 | ATHA | $13.4K | Award | 10,000 | $1.34 | Discretionary |
| Jan 5, 2024 | ATHA | $7.0K | Sale | 2,412 | $2.91 | Discretionary |
| Jan 5, 2024 | ATHA | $7.0K | Sale | 2,412 | $2.91 | Discretionary |
| Jan 4, 2024 | ATHA | $0 | Award | 10,000 | $N/A | Discretionary |
| Jan 4, 2024 | ATHA | $0 | Award | 10,000 | $N/A | Discretionary |
| May 18, 2023 | ATHA | $18.7K | Award | 7,767 | $2.41 | Discretionary |
| May 18, 2023 | ATHA | $18.7K | Award | 7,767 | $2.41 | Discretionary |
| Jun 23, 2022 | ATHA | $7.0K | Sale | 2,614 | $2.69 | Discretionary |
| Jun 22, 2022 | ATHA | $0 | Award | 10,000 | $N/A | Discretionary |
| May 18, 2022 | ATHA | $24.0K | Award | 3,396 | $7.06 | Discretionary |